Livforsakringsbolaget Skandia Omsesidigt buys $47,036,155 stake in Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ) : Livforsakringsbolaget Skandia Omsesidigt scooped up 18,200 additional shares in Johnson & Johnson during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 15, 2016. The investment management firm now holds a total of 381,973 shares of Johnson & Johnson which is valued at $47,036,155.Johnson & Johnson makes up approximately 2.01% of Livforsakringsbolaget Skandia Omsesidigt’s portfolio.

Other Hedge Funds, Including , Pioneer Trust Bank N Aor boosted its stake in JNJ in the latest quarter, The investment management firm added 950 additional shares and now holds a total of 37,103 shares of Johnson & Johnson which is valued at $4,568,863. Johnson & Johnson makes up approx 2.70% of Pioneer Trust Bank N Aor’s portfolio.Chicago Trust Co Na boosted its stake in JNJ in the latest quarter, The investment management firm added 469 additional shares and now holds a total of 29,916 shares of Johnson & Johnson which is valued at $3,675,181. Johnson & Johnson makes up approx 1.55% of Chicago Trust Co Na’s portfolio.Daiwa Sb Investments Ltd. boosted its stake in JNJ in the latest quarter, The investment management firm added 230 additional shares and now holds a total of 2,970 shares of Johnson & Johnson which is valued at $364,865. Johnson & Johnson makes up approx 0.10% of Daiwa Sb Investments Ltd.’s portfolio.Nexus Investment Management boosted its stake in JNJ in the latest quarter, The investment management firm added 400 additional shares and now holds a total of 9,100 shares of Johnson & Johnson which is valued at $1,117,935. Johnson & Johnson makes up approx 0.21% of Nexus Investment Management’s portfolio.Stock Yards Bank Trust Co boosted its stake in JNJ in the latest quarter, The investment management firm added 4,738 additional shares and now holds a total of 85,885 shares of Johnson & Johnson which is valued at $10,501,159. Johnson & Johnson makes up approx 1.40% of Stock Yards Bank Trust Co’s portfolio.

Johnson & Johnson opened for trading at $123 and hit $123.22 on the upside on Monday, eventually ending the session at $123.14, with a gain of 0.11% or 0.14 points. The heightened volatility saw the trading volume jump to 65,99,199 shares. Company has a market cap of $338,714 M.

On the company’s financial health, Johnson & Johnson reported $1.74 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.68. The company had revenue of $18482.00 million for the quarter, compared to analysts expectations of $17985.80 million. The company’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.71 EPS.

Many Wall Street Analysts have commented on Johnson & Johnson. Standpoint Research Initiated Johnson & Johnson on May 20, 2016 to “Sell”, Price Target of the shares are set at $94.Company shares were Reiterated by RBC Capital Mkts on Apr 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 125 from a previous price target of $122 .Company shares were Reiterated by Piper Jaffray on Apr 20, 2016 to “Neutral”, Firm has raised the Price Target to $ 106 from a previous price target of $105 .

Johnson & Johnson is a holding company. The Company is engaged in the research and development manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Company’s primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer Pharmaceutical and Medical Devices. The Company’s subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Company’s research facilities are located in the United States Belgium Brazil Canada China France Germany India Israel Japan the Netherlands Singapore Switzerland and the United Kingdom.

Leave a Reply

Johnson & Johnson - Is it time to Sell?

Top Brokerage Firms are advising their investors on Johnson & Johnson. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.